Загрузка...
Nucleic acid-based vaccines targeting respiratory syncytial virus: Delivering the goods
Respiratory syncytial virus (RSV) is a massive medical burden on a global scale. Infants, children and the elderly represent the vulnerable populations. Currently there is no approved vaccine to protect against the disease. Vaccine development has been hindered by several factors including vaccine e...
Сохранить в:
| Опубликовано в: : | Hum Vaccin Immunother |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5703370/ https://ncbi.nlm.nih.gov/pubmed/28881156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1363134 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|